Results 1 to 10 of about 393,681 (269)

The evolving role of cytokines for CAR-T cell manufacturing and beyond. [PDF]

Nat Biomed Eng
Guaza-Lasheras M, Nimmerfroh J, Schwarz D, de Gruijl TD, Hartmann J, Klein C, Läubli H, Lotem M, Mittelstaet J, Paget C, Hadrup SR, Schallenberg S, Thor Straten P, Theurich S, Venetz D, Zippelius A, Zitvogel L, Kobold S.   +17 more
europepmc   +1 more source

CAR-M Therapy: From Concept to Clinical Translation in Solid Tumors. [PDF]

Cells
Miao C, Chen Z, Chen J, Sun J, Sun Y, Shi W, Xu W, Li Y, Zhao X.   +8 more
europepmc   +1 more source

Overcoming fratricide of CD86 targeting CAR-T cells by defined logic-gate CAR strategy. [PDF]

Exp Hematol Oncol
Riet T, Lennartz S, Bösing N, Prinz LF, Dähn L, Scheid C, Hallek M, Chmielewski MM.   +7 more
europepmc   +1 more source

B7 homolog 3-targeted CAR-T cells secreting EGFR T-cell engagers for improved control of glioblastoma progression. [PDF]

Mol Biomed
Zhang Z, Yang N, Zeng H, Chen Y, Lu H, Xu L, Wang Z, Wang G, Zhou L, Tong A.   +9 more
europepmc   +1 more source

CAR T-cell expansion after idecabtagene vicleucel is a predictor of outcomes in multiple myeloma. [PDF]

Hemasphere
Ferment B, Ouedrani A, Talbot A, Mouri N, Zarnitzky P, Stammler R, Vaugeois T, Diep A, Harel S, Royer B, Theves F, Forgeard N, Allain V, Caillat-Zucman S, Arnulf B.   +14 more
europepmc   +1 more source

Recurrent myocardial infarction caused by peripartum left main spontaneous coronary artery dissection, extending to the left anterior descending artery and left circumflex artery

Cardiology Journal, 2020
Géraldine Godin, Juan F. Iglesias, Stéphane Noble, Marco Roffi, Sophie Degrauwe   +4 more
doaj   +1 more source

Dual-target CAR-T cell therapy: latest updates from the 2025 ASH annual meeting. [PDF]

Exp Hematol Oncol
Feng S, Kong R, Xiao L, Zhou X.
europepmc   +1 more source

Implications of Rho GTPase signaling in cancer immunotherapy. [PDF]

Biochem Soc Trans
Cai M, Guo F, Zheng Y.
europepmc   +1 more source

CARs for macrophages [PDF]

Nature Medicine, 2020
openaire   +2 more sources

Exploring CAR cell therapies beyond CAR-T for myeloid malignancies. [PDF]

J Biomed Sci
Li YR, Chen Y, Yang L.
europepmc   +1 more source